Safety Shot Inc (SHOT)
USD 0.48
(-9.45%)
USD 0.48
(-9.45%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -74.45 Thousand USD | -107.25% |
| 2022 | 1.02 Million USD | 91.67% |
| 2021 | 535.48 Thousand USD | 21.4% |
| 2020 | 441.09 Thousand USD | 3912.73% |
| 2019 | -11.56 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 101.21 Thousand USD | 108.88% |
| 2024 Q1 | -2.31 Million USD | -1453.18% |
| 2023 Q1 | 246.64 Thousand USD | 2722.49% |
| 2023 Q3 | 58.38 Thousand USD | -88.41% |
| 2023 FY | -289.63 Thousand USD | -128.22% |
| 2023 Q4 | -149.18 Thousand USD | -355.52% |
| 2023 Q2 | 503.74 Thousand USD | 104.24% |
| 2022 FY | 1.02 Million USD | 91.67% |
| 2022 Q4 | -9405.00 USD | -102.27% |
| 2022 Q3 | 414.3 Thousand USD | -18.0% |
| 2022 Q2 | 505.24 Thousand USD | 331.05% |
| 2022 Q1 | 117.21 Thousand USD | -64.13% |
| 2021 Q3 | 2159.00 USD | -98.81% |
| 2021 Q4 | 326.75 Thousand USD | 15034.65% |
| 2021 FY | 535.48 Thousand USD | 21.4% |
| 2021 Q1 | 25.39 Thousand USD | -78.96% |
| 2021 Q2 | 181.17 Thousand USD | 613.46% |
| 2020 Q4 | 120.67 Thousand USD | 47.65% |
| 2020 Q2 | 220.87 Thousand USD | 1139.19% |
| 2020 Q1 | 17.82 Thousand USD | 238.21% |
| 2020 FY | 441.09 Thousand USD | 3912.73% |
| 2020 Q3 | 81.72 Thousand USD | -63.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q4 | -12.89 Thousand USD | -762.69% |
| 2019 Q3 | 1946.00 USD | 414.38% |
| 2019 FY | -11.56 Thousand USD | 0.0% |
| 2019 Q2 | -619.00 USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| ANI Pharmaceuticals, Inc. | 305.3 Million USD | 100.024% |
| Aquestive Therapeutics, Inc. | 29.75 Million USD | 100.25% |
| Collegium Pharmaceutical, Inc. | 326.16 Million USD | 100.023% |
| Cosmos Health Inc. | 4.34 Million USD | 101.712% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 96.911% |
| Esperion Therapeutics, Inc. | 73.06 Million USD | 100.102% |
| Cronos Group Inc. | 6.99 Million USD | 101.065% |
| Incannex Healthcare Limited | 12 Thousand USD | 720.475% |
| Kala Pharmaceuticals, Inc. | -303 Thousand USD | 75.427% |
| Lifecore Biomedical, Inc. | 41.85 Million USD | 100.178% |
| Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 90.014% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 100.893% |
| Sunshine Biopharma, Inc. | 8.33 Million USD | 100.893% |
| SCYNEXIS, Inc. | 124.51 Million USD | 100.06% |
| Theratechnologies Inc. | 62.12 Million USD | 100.12% |
| Alpha Teknova, Inc. | 10.29 Million USD | 100.723% |
| Universe Pharmaceuticals INC | 10.07 Million USD | 100.739% |
| Pacira BioSciences, Inc. | 490.3 Million USD | 100.015% |
| Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | 101.569% |
| Dynavax Technologies Corporation | 182.11 Million USD | 100.041% |
| Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 100.017% |
| Radius Health, Inc. | 307.71 Million USD | 100.024% |
| China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | 113.441% |
| Alvotech | -69.42 Million USD | 99.893% |
| Intra-Cellular Therapies, Inc. | 430.62 Million USD | 100.017% |
| SIGA Technologies, Inc. | 122.09 Million USD | 100.061% |
| Shineco, Inc. | 882.16 Thousand USD | 108.44% |
| Silver Spike Investment Corp. | 8.1 Million USD | 100.919% |
| Journey Medical Corporation | 52.52 Million USD | 100.142% |
| Petros Pharmaceuticals, Inc. | 4.19 Million USD | 101.777% |
| Embecta Corp. | 749.9 Million USD | 100.01% |
| Harrow Health, Inc. | 90.55 Million USD | 100.082% |
| Procaps Group, S.A. | 239.56 Million USD | 100.031% |
| Biofrontera Inc. | 16.62 Million USD | 100.448% |
| DURECT Corporation | 6.83 Million USD | 101.09% |
| PainReform Ltd. | -15 Thousand USD | -396.38% |
| Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 100.014% |
| OptiNose, Inc. | 62.35 Million USD | 100.119% |
| RedHill Biopharma Ltd. | 3.05 Million USD | 102.438% |
| Organogenesis Holdings Inc. | 309.79 Million USD | 100.024% |
| Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 100.222% |
| ProPhase Labs, Inc. | 16.23 Million USD | 100.459% |
| Phibro Animal Health Corporation | 312.48 Million USD | 100.024% |
| Procaps Group S.A. | 239.56 Million USD | 100.031% |
| TherapeuticsMD, Inc. | 1.3 Million USD | 105.719% |
| Viatris Inc. | 6.43 Billion USD | 100.001% |
| Rockwell Medical, Inc. | 8.7 Million USD | 100.855% |
| Aytu BioPharma, Inc. | 54.58 Million USD | 100.136% |
| Tilray Brands, Inc. | 223.35 Million USD | 100.033% |
| PetIQ, Inc. | 252.74 Million USD | 100.029% |
| Talphera, Inc. | -4.89 Million USD | 98.479% |
| Neurocrine Biosciences, Inc. | 1.84 Billion USD | 100.004% |
| Alimera Sciences, Inc. | 61.17 Million USD | 100.122% |
| Assertio Holdings, Inc. | 125.04 Million USD | 100.06% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | -993.187% |
| Avadel Pharmaceuticals plc | 27.11 Million USD | 100.275% |
| Hempacco Co., Inc. | -1.21 Million USD | 93.876% |
| Alvotech | -69.42 Million USD | 99.893% |
| Lantheus Holdings, Inc. | 709.54 Million USD | 100.01% |
| Kamada Ltd. | 52.59 Million USD | 100.142% |
| Currenc Group, Inc. | 17.35 Million USD | 100.429% |
| Indivior PLC | 907 Million USD | 100.008% |
| Evoke Pharma, Inc. | 4.97 Million USD | 101.495% |
| Flora Growth Corp. | 17.73 Million USD | 100.42% |
| Cyclo Therapeutics, Inc. | -2.41 Million USD | 96.911% |
| Evolus, Inc. | 140.52 Million USD | 100.053% |
| HUTCHMED (China) Limited | 453.55 Million USD | 100.016% |
| Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 100.022% |
| Akanda Corp. | 111.44 Thousand USD | 166.808% |